Redx Pharma previews development plans for idiopathic pulmonary fibrosis and fibrostenotic Crohn’s disease
UK News
Just announced: upcoming HIV late-stage clinical trials
Clinical Trials Arena examines recently announced Phase III studies in the HIV therapeutic landscape.
Vergent Bioscience shares Phase IIb plans for oncology imaging agent
FDA’s multiple endpoints guidance: enough to tackle the growing trial complexity?
Just announced: upcoming late-stage clinical trials in weight loss and diabetes
Missing data: risk of assessment bias joins the long tail of Covid-19 impact on clinical trials
X4 Pharma previews Phase III trial plans in rare blood disorder
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
